• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Esophagus >Current status of esophageal cancer treatment in Asia
【24h】

Current status of esophageal cancer treatment in Asia

机译：亚洲食管癌治疗的现状

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Esophageal cancer is becoming a different disease in Asian and Western countries. The rapidly rising incidence of adenocarcinoma of the lower esophagus and cardia has replaced squamous cell cancers as the predominant cell type in the west. The different cell type and tumor location to some extent influence how the disease is treated; other factors are cultural and the way health care is financed. The goals of treatment, however, are the same; to provide long-term cure with minimal morbidity and mortality and to preserve patients quality of life. Surgical resection has remained the mainstay treatment in Asia. Improvement in surgical outcome has taken place in many centers throughout Asia in the past two decades. Emphasis has been centered on epidemiology of the disease, reducing morbidity and mortality of esophagectomy, and identifying effective surgical or nonsurgical methods of treatments. Randomized controlled trials are also increasingly employed to test many unresolved problems. The Asian contributions are elaborated with specific examples from Japan, Hong Kong, and China.
机译：食道癌正在成为亚洲和西方国家的另一种疾病。下食道和card门腺癌的发病率迅速上升，已取代鳞状细胞癌成为西方的主要细胞类型。不同的细胞类型和肿瘤位置在一定程度上影响疾病的治疗方式。其他因素是文化和医疗保健筹资方式。然而，治疗的目标是相同的。以最低的发病率和死亡率提供长期治愈，并保持患者的生活质量。手术切除一直是亚洲的主要治疗手段。过去二十年来，亚洲许多中心的手术结局已有所改善。重点已放在疾病的流行病学，降低食管切除术的发病率和死亡率以及确定有效的手术或非手术治疗方法上。随机对照试验也越来越多地用于测试许多未解决的问题。通过来自日本，香港和中国的具体实例详细阐述了亚洲的贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号